SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

ONDS is trending as the community discusses the stock's volatility and potential for a short squeeze. Recent news of a contract win is fueling optimism, though a proposed increase in authorized shares has sparked concerns about dilution. Bullish investors are focused on the company's long-term prospects in the drone and counter-UAS technology sectors.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is trending following positive data from Roche on a similar breast cancer drug, sparking significant intraday volatility and a surge in price. The community is actively debating whether this jump is justified, discussing potential short squeezes, imminent offerings, and the overall valuation of OLMA in light of the news. Some traders are wary of a potential pullback, while others see further upside based on pipeline potential and analyst upgrades.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending due to its GPU-accelerated quantum algorithm simulation and compatibility with NVIDIA's CUDA-Q, sparking discussions about accelerated quantum computing. Investors are speculating on potential partnerships, future growth, and the company's positioning within the quantum computing sector. Community members are also discussing the potential for a short squeeze.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending as community members speculate about a potential acquisition by Nestle, fueled by rumors and recent activity, including workforce reductions.  The discussion revolves around a possible buyout price and what a deal would mean for shareholders.  Some traders are pointing to technical indicators and options activity, while others express frustration with the company's long-term performance and management.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending amid ongoing speculation of a potential bidding war, with Paramount Skydance, Comcast, and Netflix all reportedly interested; the community is closely watching for developments as the November 20th bid deadline approaches. Community members are discussing the potential deal price and possible outcomes, with some anticipating bids exceeding the previously rejected $23.50 offer and speculating about who might acquire the company's assets.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as retail investors discuss the stock holding its 200-day moving average and anticipate a breakout, with some pointing to a potential 'W' pattern forming. Community members are actively trading the swings and expressing excitement around potential catalysts, including a possible World Cup contract and Nvidia's earnings. Bullish sentiment seems to be increasing as traders hope for a power hour surge and speculate on news of new contracts soon.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending as anticipation builds for presentations at the upcoming AASLD Liver Meeting, with the community focused on new biomarker data and potential partnerships. Discussion is centered on Belapectin's potential synergy with GLP-1 drugs and speculation about a possible short squeeze, given the high short interest. Investors are closely watching for any indications of a potential buyout before the year's end.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

ARWR is trending due to the FDA approval of REDEMPLO for familial chylomicronemia syndrome, marking its first drug approval. The community is excited about the company transitioning to a commercial stage and its robust pipeline, with some drawing comparisons to ALNY's market capitalization. Discussions also revolve around the drug's advantages over competitors and potential partnerships.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target (TGT) is trending as investors anticipate upcoming earnings and assess its potential as a value play, considering its lower valuation compared to industry peers. Community members are weighing the possibility of a post-earnings move to $100+, while some caution against potential economic headwinds impacting retail and consumer spending during the holiday season.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending due to positive clinical trial results for its drug Tradipitant in reducing nausea and vomiting induced by the popular weight loss drug Wegovy. The community is buzzing about the potential buyout scenarios and higher valuation, while some express concerns over management's past decisions and spending habits. Bullish sentiment prevails with many expecting the company's market value to increase significantly.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aeries Technology Inc. (AERT), an AI-powered transformation solutions provider for private equity-backed companies, said on Thursday that it has secured a major multi-year contract valued at up to $8 million annually.&nbsp;The agreement is with a leading global marketing and tech firm aiming to expand its presence in India and strengthen its AI delivery infrastructure.Following the announcement,&nbsp;<a href="https://stocktwits.com/symbol/AERT">Aeries Technology</a> stock rose by over 51% on Thursday afternoon. On Stocktwits, retail sentiment around the stock jumped to ‘extremely bullish’ from ‘bearish’ territory the previous day. At the same time, message volume improved to ‘extremely high’ from ‘extremely low’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:937/117;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_18_123837_png_8ee8e42661.webp" alt="AERT’s Sentiment Meter and Message Volume as of 12:30 p.m. ET on Sep. 18, 2025 | Source: Stocktwits" width="937" height="117"><figcaption>AERT’s Sentiment Meter and Message Volume as of 12:30 p.m. ET on Sep. 18, 2025 | Source: Stocktwits</figcaption></figure>A bullish Stocktwits user commended the new contract.<stembedurl>https://stocktwits.com/Marketman707/message/629126302</stembedurl>The new alliance is a key component of the client’s broader strategy to scale operations and enhance capabilities in artificial intelligence.On September 4, Aeries unveiled plans to scale its workforce across India and Mexico, with plans to hire more than 500 professionals in India over the next year, across various fields, including artificial intelligence, technology, finance, and business operations.&nbsp;The majority of new hires will fill specialized roles in the field of AI. These teams will be responsible for building scalable AI platforms, advanced data processing pipelines, and real-time decision engines.&nbsp;The expansion will be supported by the opening of new offices in major Indian cities, including Mumbai, Bengaluru, Hyderabad, and Pune. Aeries is also betting big on Mexico with plans to enhance its presence in Guadalajara.Aeries Technology's stock has declined by over 7% in 2025 and by more than 61% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/satya-nadella-says-microsoft-wisconsin-hub-will-deliver-10-x-performance-of-fastest-supercomputer-today/chD2Gk9R3bi">Satya Nadella Says Microsoft’s Wisconsin Hub ‘Will Deliver 10x’ Performance Of Fastest Supercomputer Today</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Aeries Technology Lands $8M Annual AI Deal: Retail Optimism Jumps

On September 4, Aeries unveiled plans to scale its workforce across India and Mexico.

Equity

On September 4, Aeries unveiled plans to scale its workforce across India and Mexico.


Aeries Expands Mexico Operations with Strategic Hires, Leveraging Global Best Practices for Accelerated Digital Transformation

GUADALAJARA, Mexico, March 25, 2024 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. ( Aeries or the Company ) (Nasdaq: AERT), a global professional services and consulting partner, today announced...

Aeries Technology, Inc (NASDAQ:AERT) Sees Large Increase in Short Interest

Aeries Technology, Inc (NASDAQ:AERT  Get Free Report) was the recipient of a large growth in short interest in the month of February. As of February 29th, there was short interest totalling...

Quickbase and Aeries Technology Enter Strategic Partnership to Enhance Global Technology and Innovation

Quickbase and Aeries Technology Enter Strategic Partnership to Enhance Global Technology and Innovation

 Quickbase and Aeries Technology Enter Strategic Partnership to Enhance Global...

Aeries Technology to Attend the 36th Annual ROTH Conference

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. ( Aeries or the Company ) (Nasdaq: AERT), a global professional services and consulting partner, announced today that Daniel...

Aeries Technology Reports Results for Third Fiscal Quarter 2024

Revenues for the third fiscal quarter of 2024 were $18.9 million, up 49% compared with the same period in 2023NEW YORK, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Aeries Technology (Nasdaq: AERT), a global...

Aeries Technology Announces Earnings Release and Conference Call Date for Fiscal Third Quarter 2024

NEW YORK, Feb. 17, 2024 (GLOBE NEWSWIRE) -- Aeries Technology (Nasdaq: AERT), a global professional services and consulting partner, today announced that the company will host a conference call to...

Confluence Opens up a Center of Excellence in Bangalore in Partnership with Aeries

Aeries to Bring Additional Scale and Efficiencies to Confluence's Business Functions and Client Experience Teams
 Aeries Technology, Inc.

 Aeries Technology, Inc.

 BANGALORE...

What Aeries Technology, Inc's (NASDAQ:AERT) ROE Can Tell Us

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Aeries Technology to Participate at the 26th Annual ICR Conference

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. ( Aeries or the Company ) (Nasdaq: AERT), a global professional services and consulting partner, announced today that Daniel...

Aeries Technology Inc. engages in the provision of professional and technology consulting services, to portfolio companies of private equity firms and middle market companies, specializing in the design, set-up, and management of Global Capability Centers for clients. It operates through the North America and Asia Pacific and Other geographical segments. The company was founded by Venu Raman Kumar and Sudhir Appukuttan Panikassery in 2012 and is headquartered in Singapore.

Current Price	$0.6265
Prev Close	$0.6501
Open	$0.65
Dividend Yield	0.00%
50-Day Moving Average	$0.6619
Beta	0.36
Avg. Volume	856,509.04
PE Ratio	-30.10

52-Week High	$2.67
52-Week Low	$0.46
Market Capitalization	$31.76M
EPS (Annual)	-$0.4576
Price to Book	-10.53
Revenue Per Employee	$50,141.43
Enterprise Value/EBITDA	N/A

AERT
Aeries Technology Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AERT News

AERTAeries Technology Inc. - Ordinary Shares - Class A